Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease
Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease have?
Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease has 30 citations in the OpenAlex counts ScholarIQ stores.
When was Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease published?
Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease has 2019 year in the ScholarIQ index.
What is the open-access status of Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease?
Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease has hybrid oa status in the ScholarIQ index.
What is the DOI of Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease?
The DOI for Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease is on the source record.
What is the PMID of Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease?
The PMID for Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease is on the source record.
What is the OpenAlex record for Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease?
The OpenAlex for Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease is on the source record.